Can Nektar Therapeutics Bounce Back from its Massive Tumble?
Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its...
Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its...
According to a report by Grand View Research Inc, the global Video Streaming market will reach and estimated USD 124.57 Billion by 2025,...
OrganiGram Holdings (NASDAQ: OGI), a prominent player in the Canadian Cannabis sector, surprised analysts and the cannabis industry alike with the announcement of...
The Meet Group (NASDAQ: MEET), a leading provider of interactive livestreaming solutions, which operates a portfolio of Social Entertainment platforms, announced its collaboration...
Catabasis Pharmaceuticals (NASDAQ: CATB), a clinical-stage Company leveraging its proprietary SMART (Safely Metabolized and Rationally Targeted) Linker drug discovery platform to treat multiple...
Accuray Inc (NASDAQ: ARAY), a Company developing robotic stereotactic radiosurgery and stereotactic body radiation therapy system, specifically the CyberKnife System, announced the data...
Huntington’s disease is a progressive degeneration of the neurons in the brain resulting in loss of cognition, motor ability, uncontrolled movements and emotional...
GreenLane Holdings Inc (NASDAQ: GNLN), a Company dealing in wholesale and retail distribution of consumption accessories and vaporization products, announced a comprehensive distribution...
ChromaDex (NASDAQ: CDXC), a nutraceutical Company focussed on improving the way people age, announced the launch of a “first-of-its-kind” Phase 1 clinical study...